The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control

Kodela Vani1, Seshi R Sompuram1, Anika K Schaedle1

  • 1Medical Discovery Partners LLC, Boston, Massachusetts (KV, SRS, AKS, AB, SAB).

Insights

Optimizing immunohistochemistry (IHC) controls is crucial for accurate results. Using well-defined analyte concentrations in positive IHC controls, rather than strong staining ones, enhances sensitivity for detecting reagent degradation.

Area of Science:

  • Biotechnology
  • Pathology
  • Laboratory Medicine

Background:

  • Clinical immunohistochemistry (IHC) laboratories require accurate and reproducible immunostains.
  • Homemade positive controls from pathological samples often have unknown epitope density, impacting control performance.
  • The effect of defined analyte concentrations on IHC control sensitivity remains unclear.

Purpose of the Study:

  • To prepare positive IHC controls (IHControls) with defined, homogeneous, and reproducible analyte concentrations for HER-2, ER, and PR.
  • To investigate the impact of analyte concentration on the sensitivity of IHC controls in detecting reagent degradation.

Main Methods:

  • Preparation of IHControls with precisely quantified analyte concentrations for HER-2, ER, and PR.
  • Evaluation of IHControls and conventional tissue controls in simulated primary antibody reagent degradation experiments.
  • Analysis of the relationship between control analyte concentration and immunostain analytic response curves.

Main Results:

  • The sensitivity of a positive IHC control in detecting reagent degradation is contingent upon its analyte concentration and its position on the immunostain's analytic response curve.
  • Positive IHC controls with analyte concentrations near or within the concentration-dependent response range exhibit the highest sensitivity.
  • Strongly staining positive controls, with analyte concentrations on the plateau of the response curve, are less sensitive to reagent degradation.

Conclusions:

  • Selecting positive IHC controls with intermediate staining intensity is more effective for revealing reagent degradation than those with strong intensity.
  • Defined analyte concentrations in positive IHC controls are critical for ensuring reliable and sensitive detection of immunostain performance issues.
  • This study highlights the importance of optimizing positive control characteristics for improved diagnostic accuracy in clinical IHC.